An evaluation of the Oxford Academic Health Science Network (AHSN) found that it is capable of promoting high quality care and delivering projects which improve patient outcomes at a cost that appears to represent good value for money.
Alternatives to coercive sanctions (ACS) seems reduce drug use and reoffending, but the evidence is equivocal and some features could make ACS more effective. Also, several common barriers prevent the use of ACS in a number of EU member states.
RAND Europe examined the past performance of 3ie, considered the possible future trends that will determine the environment within which 3ie might be operating, and explored three scenarios for the future to understand potential future options for 3ie.
The Forces in Mind Trust (FiMT) supports families of UK Service leavers as they transition to civilian life. To help the FiMT, more research is needed in the areas of family engagement, family breakdown, housing and spousal employment.
A review of the National Trading Standards Scams Team pilot finds that it delivers significant value for money, saving up to £27 per £1 invested by identifying victims of mass marketing fraud and reducing future victimisation.
Illegal drug transactions on cryptomarkets have tripled since 2013, with revenues doubling. But at $12-21 (€10.5-18.5) million a month, this is clearly a niche market compared to the traditional offline market, estimated at $2.3 (€2) billion a month in Europe alone.
Employees are less likely to report errors if they work for organisational cultures that focus on 'human error' as the cause of accidents. This was one of the key findings of research for TOTAL on initiatives that may limit the risk of accidents in the oil and gas industry.
Researchers evaluated a new model of liaison and diversion (L&D) schemes, which aim to improve early identification of a range of health vulnerabilities among people passing through the UK youth or adult criminal justice system.
The UK’s roads, railways and airports are some of the most congested in the world. RAND Europe, in collaboration with Risk Solutions, explored how emerging technologies might make the transport system more efficient and effective by the year 2035.
RAND Europe explored whether stakeholders agreed with and anticipated problems implementing the recommendations of the "Living with Breathlessness" research programme to improve end-of-life care for patients with advanced chronic obstructive pulmonary disease (COPD).
Rates of assault against police officers are 15% higher when they wear cameras, possibly because they feel more confident about reporting assaults once they are captured on camera or because the officers did not keep their cameras on throughout their shift.
To help NHS England improve its new Integrated Personal Commissioning programme, RAND Europe defined a plan for the programme's evaluation and worked with the nine demonstrator sites to ensure the needed data were collected.
Research shows that, across OECD countries, higher levels of social spending are strongly associated with better health, and the association is particularly strong for public social spending. Additionally, the association between social spending and better health strengthens over time.
To inform the direction and strategy of Q, an initiative led by the Health Foundation and supported and co-funded by NHS England, RAND Europe evaluated the initiative and provided real-time feedback throughout its first year. The evaluation focused on identifying problems and practical solutions.
Population-scale genome-sequencing initiatives have evolved over the past two decades. RAND Europe examines progress made in terms of the initiatives' scientific, technological and biomedical contributions, and their influence on the institutions that govern science and innovation more widely.
A series of social innovation pilot projects across Europe aim to support the growth of European social finance markets and the development of capacities within social business and young entrepreneurship. RAND Europe and Ecorys evaluated the pilots and hosted a series of interactive workshops to encourage an exchange of experiences.
Although quality of life considerations are important for all cancer treatment, they may be particularly important when survival prospects are limited. RAND Europe explored whether, when, how, and what quality of life assessment tools are used in the treatment and care of cancer patients.
The King’s Policy Institute, the Office of Health Economics and RAND Europe developed a methodology to estimate how many pounds of pharmaceutical industry R&D is stimulated in the UK by public or charity spending on medical research.
The European Programme for Integration and Migration (EPIM) is a €3 million collaborative initiative of 12 major foundations to improve integration of and outcomes for migrants in Europe through advocacy, capacity-building and policy change. EPIM had RAND Europe evaluate the achievements and impacts of their work in 2012-2015, to ensure accountability and enable learning that can be acted on during the course of the programme.
Through CCHSR, RAND Europe helped to evaluate the University College London Hospitals partnership with Macmillan Cancer Centre, a programme offering patient and carer support, and provided recommendations for its continued improvement.
To help the OECD understand key elements of health and social care commissioning in Northern Ireland, researchers assessed how effectively the population's needs are being met, the use of strategic planning, and how well the system incentivises high quality, value for money service provision.
To support the coordination of mental health research, RAND Europe mapped the research funding ‘ecosystem’. Researchers explored who the major funders are, what kinds of research they support, and how their strategies relate to one another.
A series of interviews and workshops helped RAND Europe evaluate three measures proposed as part of the NHS Accelerated Access Review interim report to encourage the adoption of innovation. RAND assessed the feasibility of the measures and factors likely to facilitate or challenge their success.